Company Filing History:
Years Active: 2024
Title: Kenneth Prentice: Innovator in rAAV Virion Production
Introduction
Kenneth Prentice is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the development of stable cell lines for the production of recombinant adeno-associated virus (rAAV) virions. His work is crucial for advancing gene therapy techniques.
Latest Patents
Kenneth Prentice holds a patent for "Stable cell lines for inducible production of rAAV virions." This patent describes polynucleotide constructs and stable cell lines that facilitate the inducible production of rAAV virions, which are essential for packaging a payload polynucleotide. He has 1 patent to his name.
Career Highlights
Prentice is currently associated with Shape Therapeutics Inc., a company focused on developing innovative gene therapies. His expertise in biotechnology and virology has positioned him as a valuable asset in the field.
Collaborations
One of his notable coworkers is Sandhya Pande, with whom he collaborates on various projects related to gene therapy and viral vector development.
Conclusion
Kenneth Prentice's contributions to the field of biotechnology, particularly through his patent on rAAV virion production, highlight his role as an innovator in gene therapy. His work continues to influence advancements in this critical area of research.